sustanon 250
sustanon 250

From the sustanon 250 senses: the taste and smell, visual disturbances (diplopia, changes in color vision), tinnitus, hearing loss.

Cardio vascular system: tachycardia, cardiac arrhythmias, lowering blood pressure , fainting, sweating, a feeling of “tides” of blood to the skin of the face sustanon 250 side effects, thrombosis of the cerebral arteries.

From the hematopoietic system: leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, haemolytic anemia.

From the urinary system: hematuria, crystalluria (particularly in alkaline urine and low urine output), glomerulonephritis, dysuria, polyuria, urinary retention, albuminuria, urethral bleeding, decreased azotovydelitelnoy renal function, interstitial nephritis.

Allergic reactions: itching, rash, blisters, accompanied by sustanon 250 bleeding and small nodules, forming scabs, drug fever, petechial hemorrhages (petechiae), swelling of the face or throat, shortness of breath, eosinophilia, vasculitis, rash, nodular erythema, exudative maltiformnaya erythema, syndrome Stevens-Johnson (malignant exudative erythema), toxic epidermal necrolysis sustanon 450, anaphylactic shock.

From the Musculoskeletal System: arthralgia, arthritis, tenosynovitis, tendon ruptures, myalgia, swelling in the joint.

Other: general weakness, superinfection (candidiasis, pseudomembranous colitis), increased sensitivity to light

From the laboratory parameters: hypoprothrombinemia, increased activity of “liver” transaminases and alkaline phosphatase, hypercreatininemia, hyperbilirubinemia, hyperuricemia, hyperglycemia.


Symptoms: nausea, vomiting, diarrhea, headache and dizziness, and in more severe cases, confusion, tremors, hallucinations, and seizures.

Treatment: symptomatic, gastric lavage, the appointment of activated charcoal and laxatives; ensure adequate intake of fluid. A specific antidote is not known. Haemodialysis sustanon 250 does not have the clinical effect of intoxication.

Interaction with other drugs

With simultaneous application of ciprofloxacin and ciprofloxacin didanosine absorption is reduced due to the formation of complexes with ciprofloxacin contained sustanon cycle in didanosine aluminum and magnesium salts.Due to the reduced activity of microsomal oxidation in hepatocytes concentration increases and extends the half-life of theophylline and / or caffeine (xanthines and others.) Of oral hypoglycemic drugs (glibenclamide – which can lead to hypoglycemia), anticoagulants, reduces prothrombin index.

Ciprofloxacin Cmax increases to 7 times tizanidine, which increases the risk of significant decrease of blood pressure and sleepiness. Simultaneous treatment with non-steroidal anti-inflammatory drugs (except acetylsalicylic acid) – increases the risk of seizures. Simultaneous administration of antacids, sucralfate, and preparations containing ions of aluminum, zinc, calcium, magnesium or iron, may cause a decrease in suction ciprofloxacin, so the interval between administration of these drugs must be at least 4 hours.

In an application tsiprofoksatsina and sustanon 250 cyclosporine nephrotoxicity is enhanced cyclosporine (requires monitoring of serum creatinine levels of 2 times per week).